PT - JOURNAL ARTICLE AU - Goldstein, Edward TI - On the changing role of individuals in different age groups in propagating the Omicron epidemic waves in France AID - 10.1101/2022.12.22.22283867 DP - 2023 Jan 01 TA - medRxiv PG - 2022.12.22.22283867 4099 - http://medrxiv.org/content/early/2023/03/02/2022.12.22.22283867.short 4100 - http://medrxiv.org/content/early/2023/03/02/2022.12.22.22283867.full AB - Objectives In late December 2022, rates of mortality in France (over 2,500 daily deaths) have reached levels not seen since April 2020, with the most pronounced increase in mortality recorded in nursing homes. Epidemics of Omicron and influenza have both contributed to those high mortality levels in late 2022. The roles of different age groups in propagating Omicron epidemics in the whole community require a better characterization, particularly given that in France, vaccination coverage for the 2nd booster for COVID-19 is limited and largely restricted to persons aged over 60y.Patients and Methods We examined the role of individuals in different age groups in propagating different waves of Omicron epidemics in France between March 1--Dec. 30, 2022 using previously developed methodology based on the relative risk (RR) statistic that measures the change in the group’s proportion among all cases before vs. after the peak of an epidemic wave. Higher value of the RR statistic for a given age group suggests a disproportionate depletion of susceptible individuals in that age group during the epidemic’s ascent (due to increased contact rates and/or susceptibility to infection).Results For the Spring wave (March 14 - May 15), the highest RR estimate belonged to children aged 10-19y (RR=1.92 (95% CI (1.18,3.12)), followed by adults aged 40-49y (RR=1.45 (1.09,1.93)) and children aged 0-9y (RR=1.31 (0.98,1.74)). For the Summer wave (June 27 – Aug. 21), the highest RR estimate belong to children aged 0-9y (RR=1.61 (1.13,2.30)) followed by children aged 10-19y (RR=1.59 (0.77,3.26)) and adults aged 20-29y (RR=1.42 (0.91,2.23)). For the Autumn wave (Sep. 18 – Nov. 12), the highest RR estimate belonged to children aged 10-19y (RR=1.65 (0.72,3.75)), followed by adults aged 30-39y (RR=1.39 (0.83,2.33)) and 20-29y (RR=1.21 (0.66,2.23)). For the Autumn-Winter Wave (Nov. 23 – Dec. 30), the highest RR estimate belonged to persons aged 30-39y (RR=1.43 (0.79,2.57)), followed by persons aged 80-89y (RR= 1.17 (0.99,1.4)) and persons aged 40-49y (RR= 1.15 (0.73,1.82))).Discussion/Conclusions Increasing booster vaccination coverage for all adults, as possibly for children should help mitigate future Omicron epidemics. The estimate for the RR statistic in persons aged 80-89y for the Autumn-Winter Omicron wave suggests that additional efforts should be considered for preventing the spread of Omicron infection in elderly persons, including in Long-Term Care facilities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study is based on aggregate, de-identified, publicly available data that can be accessed through refs. 1,20,21 https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-chiffres-cles-et-evolution-de-la-covid-19-en-france-et-dans-le-monde https://www.data.gouv.fr/fr/datasets/donnees-hospitalieres-relatives-a-lepidemie-de-covid-19/ https://www.insee.fr/fr/statistiques/2381472#graphique-Donnes